59,235 Shares in RA Medical Systems Inc (RMED) Acquired by Lisanti Capital Growth LLC
Lisanti Capital Growth LLC acquired a new stake in shares of RA Medical Systems Inc (NYSE:RMED) in the 3rd quarter, Holdings Channel reports. The institutional investor acquired 59,235 shares of the company’s stock, valued at approximately $1,078,000.
Separately, Rockefeller Capital Management L.P. bought a new stake in RA Medical Systems during the third quarter worth $120,000.
Several equities research analysts recently issued reports on RMED shares. SunTrust Banks started coverage on RA Medical Systems in a report on Monday, October 22nd. They set a “buy” rating and a $16.00 price target for the company. Cantor Fitzgerald started coverage on RA Medical Systems in a report on Monday, October 22nd. They set an “overweight” rating and a $21.00 price target for the company. Piper Jaffray Companies started coverage on RA Medical Systems in a report on Monday, October 22nd. They set an “overweight” rating and a $23.00 price target for the company. Finally, Maxim Group started coverage on RA Medical Systems in a report on Friday, November 2nd. They set a “buy” rating and a $23.00 price target for the company.
ILLEGAL ACTIVITY NOTICE: This story was first published by Daily Political and is owned by of Daily Political. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.dailypolitical.com/2018/11/10/59235-shares-in-ra-medical-systems-inc-rmed-acquired-by-lisanti-capital-growth-llc.html.
RA Medical Systems Company Profile
Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.
Read More: Understanding the different types of bonds
Want to see what other hedge funds are holding RMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RA Medical Systems Inc (NYSE:RMED).
Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.